Citations

Showing 10 of 108104 citations.

Movement disorder society criteria for clinically established early Parkinson's disease
Berg, Daniela , Adler, Charles H. , Bloem, Bastiaan R. , Gasser, Thomas , Halliday, Glenda M. , Lang, Anthony E. , Lewis, Simon J.G. , Li, Yuan , Liepelt‐Scarfone, Inga , Marek, Kenneth , Maetzler, Corina , Mi, Taomian, Oertel, Wolfgang H. , Olanow, C. Warren , Ríos‐Romenets, Silvia, Schäffer, Eva, Seppi, Klaus , Heim, Beatrice , Slow, Elizabeth , Bledsoe, Ian O. , Deuschl, Günther , Halliday, Glenda , Lang, Anthony E , Deuschl, Günther , Adler, C H , Lewis, Simon J G , Seppi, Klaus , Heim, Beatrice , Chan, Piu , Goetz, Christopher G. , Litvan, Irene , Obeso, Jose Angel , Poewe, Werner H , Stern, Matthew , Postuma, Ronald B.

Mayo Clinic

Movement Disorders | August 26, 2018 | Volume: 33 | Issue: 10 | Pages: 1643-1646

10.1002/mds.27431 | PMID 30145841 Get It

ABSTRACTBackground: In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease (PD). Although recent validation studies suggest high accuracy, one unmet need is for highly specific criteria for clinical trials in early/de novo PD.Objectives: The objective of this study was to generate and test a PD diagnostic criteria termed “clinically established early PD.”Methods: We modified the Movement Disorder Society criteria to increase specificity for early PD by removing all disease duration components and changing red flags to absolute exclusions. We then estimated the sensitivity/specificity of clinically established early PD criteria in patients with disease duration <5 years, selected from a 626‐patient validation study.Results: After documentation of parkinsonism, 18 individual exclusion criteria are assessed that preclude the diagnosis of “clinically established early PD.” Among 212 PD and 152 non‐PD patients, the estimated specificity was 95.4%, with 69.8% sensitivity.Conclusions: We describe high‐specificity criteria for de novo PD, which are freely available for use in clinical trials. © 2018 International Parkinson and Movement Disorder Society
Evaluation of anticoagulation use and subsequent stroke in patients with atrial fibrillation after empiric surgical left atrial appendage closure: A retrospective case‐control study
Johnsrud, Daniel O. , Melduni, Rowlens M. , Lahr, Brian D. , Greason, Kevin L. , Lahr, Brian, Yao, Xiaoxi , Noseworthy, Peter A.

Mayo Clinic

Clinical Cardiology | August 25, 2018 | Volume: 41 | Issue: 12 | Pages: 1578-1582

10.1002/clc.23066 | PMID 30144129 Get It

BackgroundSurgical exclusion of the left atrial appendage (LAA) can be performed at the time of cardiac operation as a potential modality to decrease cardioembolic risk attributable to atrial fibrillation (AF), but it remains unclear if this decreases stroke incidence. Furthermore, it is not known whether LAA exclusion impacts the decision to discontinue anticoagulation impacting subsequent stroke risk.HypothesisLAA exclusion does not significantly alter subsequent anticoagulation use or stroke incidence.MethodsWe studied 124 patients from Olmsted County with prior history of AF who underwent cardiac surgery at our institution between 1993 and 2015. Patients were divided into two groups on the basis of LAA exclusion and matched (1:1) according to 16 pretreatment variables using propensity scores obtained from a logistic regression model. Outcome data collected through chart review for survival, stroke, and the presence and duration of anticoagulation were compared between groups.ResultsThe proportion of patients receiving anticoagulation at discharge and at 5 years was not significantly different between patients who underwent LAA exclusion and those who did not; 90% vs 81%, P = 0.156, 48% vs 49%, P = 0.722, respectively. On Kaplan‐Meier analysis there were no significant differences in time free from stroke between cases and controls. Patients discharged on oral anticoagulation (OAC) had significantly lower risk of stroke (HR = 0.19, 95% confidence interval [CI] = 0.06‐0.59, P = 0.004), independent of whether LAA closure was used.ConclusionLAA exclusion did not appear to reduce early or late stroke. Only OAC was associated with a reduction in stroke risk, underscoring the need for continued anticoagulation in high‐risk patients.
Morbid Obesity Increases the Risk of Postoperative Wound Complications, Infection, and Repeat Surgical Procedures Following Upper Extremity Limb Salvage Surgery for Soft Tissue Sarcoma
Houdek, Matthew T. , Griffin, Anthony M. , Houdek, Matthew T , Ferguson, Peter C. , Wunder, Jay S.

Mayo Clinic

HAND | August 25, 2018 | Volume: 14 | Issue: 1 | Pages: 114-120

10.1177/1558944718797336 | PMID 30145914 Get It

Background: Obesity is a known risk factor for wound complications; however, unlike elective upper extremity procedures, where obesity can be modified preoperatively, excision of soft tissue sarcomas (STSs) is not elective, and as such, obesity cannot be modified. There is a paucity of data concerning the impact of obesity on wound healing in upper extremity sarcoma surgery. Methods: A total of 261 (159 males and 102 females) patients with a STS of the upper extremity from 2006-2014 were reviewed. The mean age and body mass index (BMI) were 56 (18-97) years and 26.6 (15.4-40.8) kg/m 2 , respectively. Sixty-nine patients (26%) were classified as obese (BMI ⩾30 kg/m 2 ): class I (obese, BMI = 30-34.9 kg/m 2 ; n = 48, 18%), class II (severely obese, BMI = 35.0-39.9 kg/m 2 ; n = 16, 6%), and class III (morbidly obese, BMI ≥ 40 kg/m 2 ; n = 5, 2%). Functional outcomes were also compared between obese and nonobese patients using the Musculoskeletal Tumor Society (MSTS) 1993 rating system and Toronto Extremity Salvage Scores (TESS). Results: Forty-nine patients (19%) sustained a wound dehiscence, delayed healing, or infection. Class III obesity increased the risk of wound complications (hazard ratio [HR] = 8.19, 95% confidence interval [CI] = 1.96-22.96, P < .001) and infection (HR = 10.09, 95% CI = 1.60-34.83, P = .01). There was no difference in the mean TESS (93 vs 90, P = .13) or MSTS93 (95 vs 93, P = .39) between obese and nonobese patients. Conclusions: The results of this study indicate morbid obesity significantly increased the risk of a postoperative wound complication and infection. However, following upper extremity limb salvage surgery, obese patients should expect to have excellent functional outcome.
Technology to Facilitate Treatment for Childhood Anxiety Disorders and Obsessive-Compulsive Disorder: Proof of Concept
Whiteside, Stephen P. H. , Biggs, Bridget K. , Hofschulte, Deanna R., Seifert, Sara J. , Kramer, K. , Biggs, Bridget K

Mayo Clinic

Evidence-Based Practice in Child and Adolescent Mental Health | August 24, 2018 | Volume: 3 | Issue: 4 | Pages: 263-273

10.1080/23794925.2018.1514547 | PMID 42100137 Get It

Interscalene Brachial Plexus Block
Amundson, Adam W. , Smith, Hugh M.

Mayo Clinic

Anesthesiology | August 24, 2018 | Volume: 129 | Issue: 6 | Pages: 1166-1166

10.1097/aln.0000000000002410 | PMID 30142089 Get It

Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease
Al‐Bawardy, Badr , Ramos, Guilherme Piovezani , Jenkins, Sarah M. , Park, Sang Hyoung , Schoenoff, Shayla, Bruining, David H. , Papadakis, Konstantinos A. , Raffals, Laura E. , Tremaine, William J., Loftus, Edward V. , Aniwan, Satimai , Schoenoff, Shayla A, Raffals, Laura, Loftus, Edward V , Ramos, Guilherme P , Willrich, Maria Alice V.

Mayo Clinic

Inflammatory Bowel Diseases | August 24, 2018 | Volume: 25 | Issue: 3 | Pages: 580-586

10.1093/ibd/izy272 | PMID 30165638 Get It

Statins and Brain Health: Alzheimer’s Disease and Cerebrovascular Disease Biomarkers in Older Adults
Przybelski, Scott A. , Graff‐Radford, Jonathan , Castillo, Anna , Lowe, Val J. , Mielke, Michelle M. , Roberts, Rosebud O., Jack, Clifford R. , Petersen, Ronald C. , Vemuri, Prashanthi , Castillo, Anna M, Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Castillo, Anna M , Ramanan, Vijay K. , Reid, Robert I. , Knopman, David S.

Mayo Clinic

Journal of Alzheimer’s Disease | August 24, 2018 | Volume: 65 | Issue: 4 | Pages: 1345-1352

10.3233/jad-180446 | PMID 30149450 Get It

Background: Statins have been proposed to reduce the risk of Alzheimer’s disease (AD). Objective: Assess whether long-term statin use was associated with neuroimaging biomarkers of aging and dementia. Methods: Methods: We analyzed neuroimaging biomarkers in 1,160 individuals aged 65+ from the Mayo Clinic Study of Aging, a population-based prospective longitudinal study of cognitive aging. Results: Statin-treated (5+ years of therapy) individuals had greater burden of mid-and late-life cardiovascular disease ( p < 0.001) than statin-untreated (≤3 months) individuals. Lower fractional anisotropy in the genu of the corpus callosum, an early marker of cerebrovascular disease, was associated with long-term statin exposure ( p < 0.035). No significant associations were identified between long-term statin exposure and cerebral amyloid or tau burden, AD pattern neurodegeneration, or white matter hyperintensity burden. Conclusions: Long-term statin therapy was not associated with differences in AD biomarkers. Individuals with long-term statin exposure had worse white matter integrity in the genu of the corpus callosum, consistent with the coexistence of higher cerebrovascular risk factor burden in this group.
BioCreative/OHNLP Challenge 2018
Wang, Yanshan , Afzal, Naveed , Wang, Liwei , Shen, Feichen , Fu, Sunyang , Fu, Sunyang , Rastegar-Mojarad, Majid , Liu, Sijia , Afzal, Naveed, Liu, Hongfang , Wang, Yanshan

Mayo Clinic

Proceedings of the 2018 ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics | August 24, 2018 | Volume: No volume available | Issue: No issue available | Pages: 575-575

10.1145/3233547.3233672 Get It

Closing the Brief Case: The Unexpected Souvenir
Asbury, Kara , Seville, Maria Teresa , Pritt, Bobbi S. , Scotch, Allison H., Kelemen, Katalin, Pritt, Bobbi, Scotch, Allison, Grys, Thomas E. , Pritt, Bobbi S , Rosenthal, Allison

Mayo Clinic

Journal of Clinical Microbiology | August 24, 2018 | Volume: 56 | Issue: 9 | Pages: No page available

10.1128/jcm.01414-17 | PMID 30150293 Get It